Dr Reddy’s Laboratories share price rises 1.97% to ₹1,165.50 on September 11

Key Takeaways

• Dr Reddy’s Laboratories gained ₹22.50 or 1.97% to ₹1,165.50 after opening at ₹1,130, which was also the session low. 
• The stock covered a ₹52 intraday range and finished ₹35.50 above its opening and low, although ₹16.50 below the high. 
• The close remained below the 50-day, 100-day and 200-day DMAs, which ranged from ₹1,193.80 to ₹1,240. 

A ₹35.50 rise from the opening print characterised Dr Reddy’s Laboratories’ September 11 session. Dr Reddy’s Laboratories share price closed at ₹1,165.50, up ₹22.50 or 1.97% from the previous close of ₹1,143. The stock opened at ₹1,130, also its intraday low, before climbing as high as ₹1,182. 

That produced a ₹52 high-low range. Although the stock retreated ₹16.50 from the session peak before the close, it still finished well above the starting level. Volume reached 2,489,941 shares, and market capitalisation stood at ₹97,282 crore. 

Its closing price remained below each of the three moving averages shown. The 50-day DMA was ₹1,193.80, a difference of ₹28.30. The gap widened to ₹56.50 against the 100-day DMA of ₹1,222 and to ₹74.50 against the 200-day DMA of ₹1,240. Those figures relate to past average prices and do not imply a future direction. 

Dr Reddy’s 52-week band ran from ₹1,101 to ₹1,415. The latest close was ₹64.50 above the annual low and ₹249.50 below the high. The September 11 low of ₹1,130 came within ₹29 of that 52-week bottom, whereas the intraday high remained ₹233 below the annual peak. 

The displayed return figures were mostly negative despite the positive session. One month stood at 0.58%, the only positive longer-period reading shown. Three months registered -8.35%, six months -11.34% and one year -10.63%. The six-month and one-year figures were relatively close, differing by 0.71 percentage point. September 11’s 1.97% gain therefore sat against a quite different pattern across the longer measurement windows.